Aclaris Therapeutics
ACRS
ACRS
128 hedge funds and large institutions have $980M invested in Aclaris Therapeutics in 2021 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
14% less capital invested
Capital invested by funds: $1.14B → $980M (-$165M)
47% less funds holding in top 10
Funds holding in top 10: 15 → 8 (-7)
Holders
128
Holding in Top 10
8
Calls
$3.32M
Puts
$2.88M
Top Buyers
| 1 | +$67.9M | |
| 2 | +$39.6M | |
| 3 | +$17.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$15.4M |
| 5 |
Holocene Advisors
New York
|
+$15.3M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$15.6M | |
| 3 | -$9.74M | |
| 4 |
SAM
Stenahm Asset Management
Guernsey
|
-$7.14M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.61M |